Screener
G&A at other companies
Other financials
Where this comes from
Reported directly by Omega Healthcare Investors in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The source filing: Omega Healthcare Investors’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 11:13 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000888491-26-000024
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Depreciation and amortization | 81,842 | 80,509 | 165,982 | 160,384 |
| Interest expense | 48,116 | 52,897 | 97,871 | 105,177 |
| Property-level expenses | 16,197 | 3,771 | 25,640 | 7,597 |
| General and administrative | 41,997 | 23,318 | 67,584 | 54,860 |
| Acquisition, merger and transition related costs | 4,660 | 2,010 | 5,774 | 3,474 |
| Impairment on real estate properties | — | 14,215 | 392 | 15,450 |
| (Recovery) provision for credit losses | (5,019) | (4,771) | (8,313) | 321 |
| Total expenses | 187,793 | 171,949 | 354,930 | 347,263 |
Item 1. Financial Statements of Omega Healthcare Investors, Inc. (Unaudited):
FAQ
- What is Omega Healthcare Investors's G&A?
- Omega Healthcare Investors (OHI) reported G&A of $42M in Q2 2026.
- How has Omega Healthcare Investors's G&A changed year-over-year?
- Omega Healthcare Investors's G&A increased by 76.2% year-over-year, from $23.84M to $42M.
- What is the long-term trend for Omega Healthcare Investors's G&A?
- Over 4 years (2021 to 2025), Omega Healthcare Investors's G&A has grown at a 12.7% compound annual growth rate (CAGR), from $64.63M to $104.14M.
- What does G&A mean?
- Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.
Ask your AI about Omega Healthcare Investors's g&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude